Pirfenidone In Idiopathic Pulmonary Fibrosis In The Real World

被引：0
|
作者：
Song, J. [1 ]
Park, J. -H. [2 ]
Heo, E. [2 ]
Kim, D. [2 ]
Chung, H. Hee Soon [2 ]
Lee, J-K. [2 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul, South Korea
[2] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Seoul, South Korea
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5403
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real World Experience of Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis
    Mulholland, S. A.
    Al Jbour, K.
    Steer, H.
    Gutsche, M.
    Foley, N.
    Srivastava, R.
    Sharp, C.
    Adamali, H. I.
    Barratt, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [2] Real World Experiences: Pirfenidone Is Well Tolerated In Patients With Idiopathic Pulmonary Fibrosis
    Chaudhuri, N.
    Leonard, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [3] Pirfenidone in Idiopathic Pulmonary Fibrosis "RECAP-itulating Safety into the Real World"
    Tzouvelekis, Argyris
    Bouros, Evangelos
    Tzilas, Vasilios
    Bouros, Demosthenes
    RESPIRATION, 2017, 94 (05) : 405 - 407
  • [4] Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
    Tzouvelekis, Argyrios
    Karampitsakos, Theodoros
    Ntolios, Paschalis
    Tzilas, Vasilios
    Bouros, Evangelos
    Markozannes, Evangelos
    Malliou, Ioanna
    Anagnostopoulos, Aris
    Granitsas, Andreas
    Steiropoulos, Paschalis
    Dimakou, Katerina
    Chrysikos, Serafeim
    Koulouris, Nikolaos
    Bouros, Demosthenes
    FRONTIERS IN MEDICINE, 2017, 4 : 1 - 1
  • [5] Real world experiences: Pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis
    Chaudhuri, Nazia
    Duck, Annette
    Frank, Rebecca
    Holme, Jayne
    Leonard, Colm
    RESPIRATORY MEDICINE, 2014, 108 (01) : 224 - 226
  • [6] Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients
    Fournier, D.
    Jouneau, S.
    Bouzille, G.
    Polard, E.
    Osmont, M. N.
    Scailteux, L. M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 77 - 78
  • [7] Real world experience on the effectiveness and safety of pirfenidone in patients with idiopathic pulmonary fibrosis in Taiwan
    Chang, Cheng-Yu
    Wei, Yu-Feng
    Chen, Chung-Yu
    Lai, Yi-Chun
    Hu, Po-Wei
    Hung, Jui-Chi
    Chu, Chi-Hsiang
    Chuang, Hsin-Tzu
    Chang, Shih-Chieh
    FRONTIERS IN MEDICINE, 2023, 10
  • [8] Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients
    Fournier, Dorine
    Jouneau, Stephane
    Bouzille, Guillaume
    Polard, Elisabeth
    Osmont, Marie-Noëlle
    Scailteux, Lucie-Marie
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 76
  • [9] Real-World Maintenance Strategies and Persistence with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
    Lancaster, L. H.
    Burg, C. A.
    Haselkorn, T.
    Yang, M.
    Corral, M.
    Stauffer, J. L.
    Huggins, J. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [10] Pirfenidone in idiopathic pulmonary fibrosis
    Swigris, J.
    Fairclough, D.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (03) : 695 - 696
12345